The First Affiliated Hospital of Soochow University, Soochow University, 188 Shizi St, Suzhou, Jiangsu 215006, P.R. China; The Affiliated Hospital of Yangzhou University, Yangzhou University, 368 Hanjiang Middle Road, Yangzhou, Jiangsu 225000, P.R. China.
The Affiliated Hospital of Yangzhou University, Yangzhou University, 368 Hanjiang Middle Road, Yangzhou, Jiangsu 225000, P.R. China.
Acta Biomater. 2021 Apr 15;125:197-207. doi: 10.1016/j.actbio.2021.02.043. Epub 2021 Mar 4.
The human amniotic membrane (HAM) collagen matrix derived from human placenta can be decellularized (dHAM) to form a natural biocompatible material. dHAM has different bioactive substances and has been used widely in human tissue engineering research. However, dHAM has some disadvantages, e.g., poor mechanical properties, easy degradation and inconvenient operation and use, so it is not conducive to large-area or full-thickness skin defect healing. To overcome these limitations, for the first time, dHAM was grafted with methacrylic anhydride (MA) to form photocrosslinked dHAM methacrylate (dHAMMA); dHAMMA was then blended with methacrylated gelatin (GelMA), followed by the addition of a photosensitizer for photocrosslinking to obtain the fast-forming GelMA-dHAMMA composite hydrogel. Further, GelMA-dHAMMA was found to have the porous structure of a bicomponent polymer network and good physical and chemical properties. In vitro experiments, GelMA-dHAMMA was found to promote fibroblast proliferation and α-smooth muscle actin (α-SMA) expression. In vivo investigations also demonstrated that GelMA-dHAMMA promotes wound collagen deposition and angiogenesis, and accelerates tissue healing. GelMA-dHAMMA inherits the good mechanical properties of GelMA and maintains the biological activity of the amniotic membrane, promoting the reconstruction and regeneration of skin wounds. Thus, GelMA-dHAMMA can serve as a promising biomaterial in skin tissue engineering. STATEMENT OF SIGNIFICANCE: Since the early 20th century, the human amniotic membrane (HAM) has been successfully used for trauma treatment and reconstruction purposes. dHAM has different bioactive substances and has been used widely in human tissue-engineering research. In this work, the dHAM and gelatin were grafted and modified by using methacrylic anhydride (MA) to form photocrosslinked dHAMMA and methacrylated gelatin (GelMA). Then, the dHAMMA and GelMA were blended with a photosensitizer to form the GelMA-dHAMMA composite hydrogel derived from gelatin-dHAM. GelMA-dHAMMA exhibits a bicomponent-network (BCN) interpenetrating structure. dHAM dydrogel has advantages, e.g., good mechanical properties, slow degradation and convenient operation, so it is conducive to large-area or full-thickness skin defect healing.
人羊膜(HAM)胶原基质来源于人胎盘,可以去细胞化(dHAM)形成天然的生物相容性材料。dHAM 具有不同的生物活性物质,已广泛应用于人体组织工程研究。然而,dHAM 存在一些缺点,如机械性能差、易降解以及操作和使用不便等,不利于大面积或全层皮肤缺损的愈合。为了克服这些局限性,我们首次将 dHAM 接枝甲基丙烯酰基(MA)形成光交联的 dHAM 甲基丙烯酰胺(dHAMMA);然后将 dHAMMA 与甲基丙烯酰化明胶(GelMA)混合,再加入光引发剂进行光交联,得到快速成型的 GelMA-dHAMMA 复合水凝胶。进一步研究发现,GelMA-dHAMMA 具有双组分聚合物网络的多孔结构和良好的物理化学性能。体外实验表明,GelMA-dHAMMA 能促进成纤维细胞增殖和α-平滑肌肌动蛋白(α-SMA)表达。体内研究也表明,GelMA-dHAMMA 能促进伤口胶原沉积和血管生成,加速组织愈合。GelMA-dHAMMA 继承了 GelMA 的良好机械性能,并保持了羊膜的生物活性,促进皮肤伤口的重建和再生。因此,GelMA-dHAMMA 可作为一种有前途的皮肤组织工程生物材料。
自 20 世纪初以来,人羊膜(HAM)已成功用于创伤治疗和重建。dHAM 具有不同的生物活性物质,已广泛应用于人体组织工程研究。在这项工作中,我们用甲基丙烯酰基(MA)接枝和修饰 dHAM 和明胶,形成光交联的 dHAMMA 和甲基丙烯酰化明胶(GelMA)。然后,将 dHAMMA 和 GelMA 与光引发剂混合形成源自明胶-dHAM 的 GelMA-dHAMMA 复合水凝胶。GelMA-dHAMMA 表现出双网络(BCN)互穿结构。dHAM 水凝胶具有良好的机械性能、缓慢降解和操作方便等优点,有利于大面积或全层皮肤缺损的愈合。